Mean weight loss of 19.2% at 6 mg with no plateau in 48-week Phase 3 trial – – Favorable safety profile consistent with other ...

U.S.-based Kailera Therapeutics and Chinese firm Jiangsu Hengrui Pharmaceuticals' experimental weight-loss drug has helped overweight patients lose up to 17.7% of body weight in a late-stage study in ...

China's rapid rise in electric vehicles, renewables, and biotechnology is reshaping global tech dominance through state ...

A meteorologist said the temperatures in northern cities are resembling parts in the south. Read more at straitstimes.com.

Innovent Biologics, the first Chinese firm to gain approval for a GLP-1 weight loss and diabetes drug, has partnered with JD Health for online distribution.

On Tuesday, Beijing’s National Bureau of Statistics (NBS) said the Chinese economy grew 5.2 percent from April to June, matching a prediction by an AFP survey of analysts and topping an official ...

With significant investments and a growing fleet of over 1,060 satellites, China poses a serious challenge to US space operations and security.

Urban planning efforts include the “Green City Expansion Plan,” featuring a “four vertical and four horizontal” network of ...

China's broad and balanced network of trading partners, innovative product offerings and resilient manufacturers will reinforce the country's confidence and capacity to navigate global trade ...

Innovent Biologics, the first Chinese company to win regulatory approval to sell a GLP-1 drug for weight loss and diabetes, ...

A 47-year veteran of the Chinese market, Panasonic operates in national economic development zones of eight cities like ...